Associate Professor
Dr. James Metz is a 1973 graduate of The Ohio State University College of Dentistry. While serving in the U.S. Army, he attained the rank of Major. Today, he maintains a restorative dental practice with an emphasis on dental sleep medicine and reconstructive dentistry along with surgical orthodontics (Surgically Facilitated Orthodontic Treatment). His practice helps address major health issues, including hypertension and type II diabetes and help restore and maintain his patients' health.
Dr. Metz is member of the American Dental Association's Scientific Investigation Committee Workgroup, which is defining the role of the Oral Appliance for the control of Obstructive Sleep Apnea. He also serves on the Scientific Investigation Committee of the American Academy of Restorative Dentistry for Sleep Dentistry. He has served on the American Academy of Dental Sleep Medicine board of directors, course development committee, public relations committee, chair for both the Introductory and Advanced Course of Dental Sleep Medicine and vice-chair of the AADSM Annual Meeting (2014). He is a board member of the Ohio Sleep Society. Dr. Metz is also the founder and current chair for the Dental Interest Group of the American Thoracic Society. As a member of the American Academy of Restorative Dentistry and International Academy of Gnathology he has pursued excellence in the field of Restorative Dentistry. Dr. Metz is also a member of the American College of Dentists, American Dental Association and previously served as president of the Muskingum Valley Dental Association.
Each year, Dr. Metz gives many graduate level continuing education courses and has been the keynote speaker for many national meetings. Dr. Metz’s current research with oral appliance therapy for obstructive sleep apnea and headache have led to the completion of a 148 consecutive patient study, soon to be published through the Northwestern University School of Medicine. The outcomes, using his techniques, have compared favorably to CPAP therapy for mild, moderate and even severe OSA patients. It has also produced and new method for the control of chronic headache.
